recombinant human coagulation factor IX (rEVO Biologics/LFB)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namerecombinant human coagulation factor IX (rEVO Biologics/LFB)
Drug Alias Namerecombinant human coagulation factor IX (ProGenetics)F-9TG
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionCoagulation factor IX stimulants
TargetsCoagulation factor IX
Therapy Area/IndicationsHemophilia B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProgenetics LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProgenetics LLCLfbRevo Biologics Inc
Active IndicationsN/A
Inactive IndicationsHemophilia B

Other Information

ATC CodeN/A
Related LinksN/A